Fresenius | FRE - Sales Revenues

Stock Price
41.25
Daily Change
-0.15 -0.36%
Monthly
-6.93%
Yearly
-2.27%
Q2 Forecast
39.19

Fresenius reported EUR5.88B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Akzo Nobel EUR 2.39B 20M Mar/2026
Alcon AG USD 2.7B 110M Dec/2025
AstraZeneca USD 15.29B 213M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 11.44B 1.78B Dec/2025
Beiersdorf EUR 2.48B 170M Mar/2026
DaVita Healthcare Partners USD 3.62B 200M Dec/2025
Demant DKK 6.26B 810M Dec/2025
E.ON EUR 21.19B 5.23B Dec/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Getinge SEK 11.07B 3.2B Dec/2024
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GN Store Nord DKK 4.68B 720M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
RWE EUR 4.56B 1.35B Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025